98 related articles for article (PubMed ID: 11997552)
1. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET.
Marom EM; Sarvis S; Herndon JE; Patz EF
Radiology; 2002 May; 223(2):453-9. PubMed ID: 11997552
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
[TBL] [Abstract][Full Text] [Related]
3. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
5. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
Downey RJ; Akhurst T; Gonen M; Vincent A; Bains MS; Larson S; Rusch V
J Clin Oncol; 2004 Aug; 22(16):3255-60. PubMed ID: 15310769
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
[TBL] [Abstract][Full Text] [Related]
7. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
[TBL] [Abstract][Full Text] [Related]
8. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
9. Localized form of bronchioloalveolar carcinoma: FDG PET findings.
Kim BT; Kim Y; Lee KS; Yoon SB; Cheon EM; Kwon OJ; Rhee CH; Han J; Shin MH
AJR Am J Roentgenol; 1998 Apr; 170(4):935-9. PubMed ID: 9530038
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma.
Ahuja V; Coleman RE; Herndon J; Patz EF
Cancer; 1998 Sep; 83(5):918-24. PubMed ID: 9731895
[TBL] [Abstract][Full Text] [Related]
11. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease.
Farrell MA; McAdams HP; Herndon JE; Patz EF
Radiology; 2000 Jun; 215(3):886-90. PubMed ID: 10831716
[TBL] [Abstract][Full Text] [Related]
12. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings.
Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK
Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET.
Schaffler GJ; Wolf G; Schoellnast H; Groell R; Maier A; Smolle-Jüttner FM; Woltsche M; Fasching G; Nicoletti R; Aigner RM
Radiology; 2004 Jun; 231(3):858-65. PubMed ID: 15105451
[TBL] [Abstract][Full Text] [Related]
14. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis.
Kanegae K; Nakano I; Kimura K; Kaji H; Kuge Y; Shiga T; Zhao S; Okamoto S; Tamaki N
Ann Nucl Med; 2007 Aug; 21(6):331-7. PubMed ID: 17705012
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336
[TBL] [Abstract][Full Text] [Related]
16. [False negative cases of F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging in small lung cancer less than 3 cm in size].
Watanabe K; Nomori H; Ohtsuka T; Naruke T; Uno K
Nihon Kokyuki Gakkai Zasshi; 2004 Sep; 42(9):787-93. PubMed ID: 15500145
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of [18F]FDG-PET imaging in small cell lung cancer.
Pandit N; Gonen M; Krug L; Larson SM
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):78-84. PubMed ID: 12483413
[TBL] [Abstract][Full Text] [Related]
18. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
19. Differentiating benign and malignant pulmonary lesions with FDG-PET.
Yang SN; Liang JA; Lin FJ; Kwan AS; Kao CH; Shen YY
Anticancer Res; 2001; 21(6A):4153-7. PubMed ID: 11911310
[TBL] [Abstract][Full Text] [Related]
20. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
